Your browser doesn't support javascript.
loading
MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells.
Sánchez-Cid, Lourdes; Pons, Mònica; Lozano, Juan José; Rubio, Nuria; Guerra-Rebollo, Marta; Soriano, Aroa; Paris-Coderch, Laia; Segura, Miquel F; Fueyo, Raquel; Arguimbau, Judit; Zodda, Erika; Bermudo, Raquel; Alonso, Immaculada; Caparrós, Xavier; Cascante, Marta; Rafii, Arash; Kang, Yibin; Martínez-Balbás, Marian; Weiss, Stephen J; Blanco, Jerónimo; Muñoz, Montserrat; Fernández, Pedro L; Thomson, Timothy M.
Afiliação
  • Sánchez-Cid L; Institute of Molecular Biology, Spanish National Research Council (IBMB-CSIC), Barcelona, Spain.
  • Pons M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Lozano JJ; Current address: Networked Biomedical Research Center for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Rubio N; Institute of Molecular Biology, Spanish National Research Council (IBMB-CSIC), Barcelona, Spain.
  • Guerra-Rebollo M; Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBER-EHD), Instituto de Salud Carlos III, Madrid, Spain.
  • Soriano A; Networked Biomedical Research Center for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Paris-Coderch L; Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
  • Segura MF; Networked Biomedical Research Center for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Fueyo R; Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
  • Arguimbau J; Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Zodda E; Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Bermudo R; Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Alonso I; Institute of Molecular Biology, Spanish National Research Council (IBMB-CSIC), Barcelona, Spain.
  • Caparrós X; Institute of Molecular Biology, Spanish National Research Council (IBMB-CSIC), Barcelona, Spain.
  • Cascante M; Department of Biochemistry and Molecular Biology, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.
  • Rafii A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Kang Y; Department of Obstetrics and Gynecology, Hospital Clinic, Barcelona, Spain.
  • Martínez-Balbás M; Department of Obstetrics and Gynecology, Hospital Clinic, Barcelona, Spain.
  • Weiss SJ; Department of Biochemistry and Molecular Biology, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.
  • Blanco J; Weill Cornell Medical College, Education City, Ar-Rayyan, Qatar.
  • Muñoz M; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
  • Fernández PL; Institute of Molecular Biology, Spanish National Research Council (IBMB-CSIC), Barcelona, Spain.
  • Thomson TM; Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
Oncotarget ; 8(48): 83384-83406, 2017 Oct 13.
Article em En | MEDLINE | ID: mdl-29137351
ABSTRACT
MicroRNAs are critical regulators of gene networks in normal and abnormal biological processes. Focusing on invasive ductal breast cancer (IDC), we have found dysregulated expression in tumor samples of several microRNAs, including the miR-200 family, along progression from primary tumors to distant metastases, further reflected in higher blood levels of miR-200b and miR-7 in IDC patients with regional or distant metastases relative to patients with primary node-negative tumors. Forced expression of miR-200s in MCF10CA1h mammary cells induced an enhanced epithelial program, aldehyde dehydrogenase (ALDH) activity, mammosphere growth and ability to form branched tubuloalveolar structures while promoting orthotopic tumor growth and lung colonization in vivo. MiR-200s also induced the constitutive activation of the PI3K-Akt signaling through downregulation of PTEN, and the enhanced mammosphere growth and ALDH activity induced in MCF10CA1h cells by miR-200s required the activation of this signaling pathway. Interestingly, the morphology of tumors formed in vivo by cells expressing miR-200s was reminiscent of metaplastic breast cancer (MBC). Indeed, the epithelial components of MBC samples expressed significantly higher levels of miR-200s than their mesenchymal components and displayed a marker profile compatible with luminal progenitor cells. We propose that microRNAs of the miR-200 family promote traits of highly proliferative breast luminal progenitor cells, thereby exacerbating the growth and metastatic properties of transformed mammary epithelial cells.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha